Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p14
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 14/22)
Character Range: 287158–290339

2% or less of metaldehyde.
METARYLPICOXAMID.
METAZACHLOR.
METHABENZTHIAZURON.
METHANOL (excluding its derivatives) in preparations containing 10 % or less of methanol except:
 (a) when included in Schedule 10; or
 (b) in preparations containing 2% or less of methanol; or
 (c) when methanol is present only as a denaturant of ethanol.
METHENAMINE in cosmetic preparations, except in preparations containing 0.15% or less of methenamine.
METHIOCARB in pelleted preparations containing 2% or less of methiocarb.
METHIOZOLIN.
METHOXYCHLOR.
METHYLATED SPIRIT(S) (being ethanol denatured with denatonium benzoate, methyl isobutyl ketone and fluorescein) except:
 (a) when included in preparations or admixtures; or
 (b) when packed in containers having a capacity of more than 5 L.
METHYLATED SPIRIT(S) when packed and labelled as a "biofuel" suitable for use in "spirit burners".
METHYLENE BLUE in preparations for veterinary use containing 50% or less of methylene blue.
METHYL ETHYL KETONE except in preparations containing 25% or less of designated solvents.
METHYL ETHYL KETONE PEROXIDE.
METHYL ISOAMYL KETONE except in preparations containing 25% or less of designated solvents.
METHYL ISOBUTYL KETONE except in preparations containing 25% or less of designated solvents.
N‑METHYL‑2‑PYRROLIDONE:
 (a) when packed in single use containers having a capacity of 2 mL or less; or
 (b) in preparations containing 50% or less of N‑methyl‑2‑pyrrolidone or preparations containing 50% or less of a mixture of any two or more of N‑methyl‑2‑pyrrolidone, N‑(N‑octyl)‑2‑pyrrolidone or N‑(N‑dodecyl)‑2‑pyrrolidone except in preparations containing 25% or less of designated solvents.
METHYL SALICYLATE in preparations containing 25% or less of methyl salicylate except:
 (a) in preparations for therapeutic use; or
 (b) in preparations containing 5% or less of methyl salicylate.
2‑METHYLTHIO‑4‑(2‑METHYLPROP‑2‑YL) AMINO‑6‑CYCLOPROPYLAMINO‑5‑ TRIAZINE.
METIRAM.
METOBROMURON except in preparations containing 50% or less of metobromuron.
METOFLUTHRIN:
 (a) in impregnated fabric mosquito repellent preparations for use in a vaporiser containing 15 mg or less of metofluthrin per disk; or
 (b) when impregnated into a polyethylene slow release matrix containing 250 mg or less of metofluthrin.
METOLACHLOR.
METRAFENONE in preparations containing 50% or less of metrafenone.
MILBEMECTIN in preparations containing 1% or less of milbemectin.
MILBEMYCIN OXIME
 (a) for the prophylaxis of heartworm in dogs and cats; or
 (b) for the treatment and prevention of flea infestations, control of ticks, gastrointestinal nematodes and heartworm in dogs, when combined with afoxolaner, in oral divided preparations each containing 150 mg or less of afoxolaner per dosage unit.
MONENSIN in intraruminal implants for cattle, each containing 35 g or less of monensin.
MONEPANTEL.
MONOETHANOLAMINE (excluding its salts and derivatives) in preparations containing 20% or less of monoethanolamine except:
 (a) when included in Schedule 4; or
 (b) in preparations containing 5% or less of monoethanolamine.
MORANTEL in preparations containing 25% or less of morantel except in preparations containing 10% or less